News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Aegerion Pharmaceuticals, Inc. Sets IPO at 5 Million Shares, $12-$14/Share
May 29, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, May 25 (Reuters) - Aegerion Pharmaceuticals Inc. on Friday set its planned initial public offering at 5 million shares for between $12 and $14 per share.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
·
2 min read
·
Dan Samorodnitsky
Drug discovery
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
May 14, 2025
·
2 min read
·
Annalee Armstrong
MASH
GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena
May 14, 2025
·
2 min read
·
Tristan Manalac
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
·
2 min read
·
Annalee Armstrong